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The employer is required to post a copy of this report for 30 days at or near the
workplace(s) of affected employees. The employer must take steps to ensure
that the posted report is not altered, defaced, or covered by other material. 
The cover photo is a close-up image of sorbent tubes, which are used by the HHE 
Program to measure airborne exposures. This photo is an artistic representation that may 
not be related to this Health Hazard Evaluation. 
































Highlights of this Evaluation 
The Health Hazard Evaluation Program received a confidential employee request for the 
National Institute for Occupational Safety and Health to conduct a health hazard evaluation at 
a hospital. The request cited concerns about exposure of hospital employees to the sporicidal 
disinfectant, OxyCide, and described symptoms experienced by employees. Employee 
symptoms noted in the health hazard evaluation request included burning eyes, nose, and 
throat; runny nose; cough; headache; dizziness; nausea; nose bleeds; asthma exacerbation; 
skin burns; and rashes. 
What We Did 
●	 We visited the hospital in April 2015 to observe cleaning staff while they performed 
their regular cleaning duties and 
to talk with them about cleaning 
product use and any related health 
concerns. 
●	 We collected 11 bulk samples of the 

diluted OxyCide in April 2015.
	
●	 We discussed the process for 

recording work-related injuries and 

illnesses with representatives from 

occupational health in April 2015.
	
●	 We returned in July 2015 to perform 

air sampling on a small number of 

environmental services employees. 

We collected full-shift and cleaning 

task-based personal time-weighted 

average air samples on 5 employees 

and analyzed the samples for 

hydrogen peroxide, peracetic acid, 

and acetic acid content. 

●	 We also administered a post-shift 

survey of acute symptoms to the five 

environmental services staff who 

wore full-shift samplers in July 2015.
	
●	 We returned in August and 

September 2015 to administer a 

health and work history questionnaire 

to a total of 163 hospital employees, 

79 of whom were environmental services staff.
	
We evaluated employee health
concerns and exposures to the three
main chemicals, hydrogen peroxide,
peracetic acid, and acetic acid, found
in the sporicidal disinfectant OxyCide.
Hydrogen peroxide, peracetic acid,
and acetic acid were detected in all
full-shift air samples. We observed
upper airway, eye, and lower airway
symptoms in staff exposed to vapors
from OxyCide. We recommend that
management tailor the use of sporicidal
disinfectants like OxyCide to areas
of high risk for healthcare-acquired
infections and minimize the use of
sporicidal disinfectants on noncritical
surfaces and in non-patient areas. We
also recommend that management
provide workplace accommodations
for employees who develop symptoms
related to the use of sporicidal
disinfectants like OxyCide. Additionally,
we provide several means to reduce
employee exposure to OxyCide.
● In September 2015, we collected an additional 45 full-shift personal air samples on 














environmental services staff and observed staff while they performed their regular 
cleaning duties. We also administered a post-shift survey of acute symptoms to the 45 
environmental services employees who participated in air sampling. We combined 
results from the September 2015 post-shift surveys of acute symptoms with the five 
post-shift surveys collected in July 2015 for a total of 50 post-shift surveys. 
●	 We performed an assessment of the heating, ventilation and air-conditioning systems in 
place in September 2015. 
●	 In April 2016, we provided a report with our interim findings and recommendations. 
What NIOSH Found 
●	 We found that OxyCide is used predominantly by environmental services staff and that 
nursing and ancillary staff predominantly use PDI® or bleach wipes for routine point-
of-care cleaning activities. 
●	 We observed environmental services employees using OxyCide on surfaces throughout 
the hospital, including patient rooms, patient bathrooms, operating rooms, and public 
bathrooms. 
●	 We observed pH measurements of the diluted OxyCide product that ranged from 2.85-
4.86. The product’s safety data sheet indicates that OxyCide should be diluted to a pH 
of 3. 
●	 We noted that some environmental services staff reported that there was no ventilation 
in some of the bathrooms that they cleaned. Several environmental services staff 
mentioned that their symptoms were worse when performing cleaning duties in the 
bathrooms, especially in the shower stalls. 
●	 We observed that the environmental services staff cleaning closets in the 3100 and 

5300 units had no supply or return airflow.
	
●	 Several employees reported previous OxyCide splashes and spills that resulted in skin 
or eye irritation. 
●	 We observed that the log of work-related injuries and illnesses (Occupational Safety 
and Health Administration’s Form 300) is maintained and generated by a third-party 
claims administrator that handles workers’ compensation claims for the hospital, which 
could lead to underestimation of work-related injuries and illnesses. 
●	 We did not observe a comprehensive system for reporting and tracking workplace 
injuries and illnesses that includes reports of near-misses, minor injuries and illnesses, 
and employee safety concerns. 
●	 We found that employees using OxyCide reported respiratory symptoms that came on 
during their shift. 




●	 We found that increased exposure to hydrogen peroxide, peracetic acid, and acetic acid 













vapors was associated with increases in acute work-related nasal and eye symptoms 
and with increased shortness of breath on level ground reported by cleaning staff. 
What the Employer Can Do 
●	 Minimize the use of sporicidal disinfectants like OxyCide in non-patient care areas. 
●	 Ensure that OxyCide dispensers are calibrated to effectively dilute the product to a pH 
of 3. If OxyCide is not effectively diluted, a pH of less than 3 may increase skin, eye, 
and respiratory symptoms in exposed employees. 
●	 Require lids for all OxyCide buckets to minimize generation of hydrogen peroxide, 
peracetic acid, and acetic acid vapors that can be inhaled. 
●	 Ensure that employees use only rags and wipes to apply OxyCide to surfaces and that 
OxyCide is not used as a spray. 
●	 Require employees to wear extended cuff nitrile gloves or rubber gloves when using 
OxyCide and goggles or a face shield while dispensing and pouring OxyCide into or 
out of the bucket on their cleaning cart. 
●	 Ensure that all heating, ventilation, and air-conditioning systems meet all ASHRAE 
standards. Specifically, ensure that additional airflow is provided to EVS closets in the 
3100 and 5300 units to meet the ASHRAE requirement of a minimum of 10 air changes 
per hour. 
●	 Ensure that all patient bathrooms meet minimum total air changes per hour as specified 
by ASHRAE. ASHRAE standard 2013-170 requires inpatient bathrooms to have at 
least 10 air changes per hour. 
●	 Review the process for Occupational Safety and Health Administration Form 300  
reporting and maintenance to assure that all reportable injuries are recorded, regardless 
of whether a workers’ compensation claim is filed. 
●	 Consider implementing a comprehensive system for reporting and tracking workplace 
injuries and illnesses that includes reports of near-misses, minor injuries and illnesses, 
and employee safety concerns. This information should be reviewed by the Safety 
Officer on a regular basis to identify hazards, implement risk-reduction strategies, and 
prevent significant injuries and illnesses. 
●	 Provide workplace accommodations to employees who develop work-related symptoms 
after exposure to OxyCide. Consider relocating employees who develop work-related 
symptoms to areas of the hospital where sporicidal disinfectants like OxyCide are used 
less frequently. 
What Employees Can Do 
● Report patient rooms or bathrooms with no ventilation or airflow to your manager. 





a face shield when dispensing and pouring OxyCide into or out of the bucket on your 
cleaning cart. 
●	 Do not use a spray bottle to apply OxyCide to surfaces. Spraying OxyCide can generate 
mists that can be hazardous for you to breathe. 
●	 Keep a lid on the OxyCide bucket whenever possible to minimize the generation of 
hydrogen peroxide, peracetic acid, and acetic acid vapors that can be inhaled. 
●	 Report new, persistent, or worsening symptoms to your personal healthcare provider 
and, as instructed by your employer, to a designated individual at your workplace.  
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Summary 
The National Institute for Occupational Safety and Health (NIOSH) received a con-
fidential employee request to conduct a health hazard evaluation at a hospital. The 
request cited concerns about exposure of hospital employees to the sporicidal disinfec-
tant, OxyCide, and described symptoms experienced by employees. Employee symp-
toms noted in the health hazard evaluation request included burning eyes, nose, and 
throat; runny nose; cough; headache; dizziness; nausea; nose bleeds; asthma exacerba-
tion; skin burns; and rashes. 
We performed a walk-through assessment of cleaning product use at the hospital on 
April 9, 2015, and informally interviewed employees about their cleaning product use 
and any related health concerns that they may have had. We learned that OxyCide was 
used predominantly by environmental services staff and that nursing and ancillary staff 
predominantly used PDI® or bleach wipes for routine point of care cleaning activities. 
We observed that OxyCide was the main cleaning product used by environmental ser-
vices staff for all surface cleaning duties. Environmental services staff were observed 
occasionally using other asthmagen-containing products including products contain-
ing ethanolamines, bleach, or quaternary ammonium compounds when cleaning glass, 
general surfaces, or bathroom surfaces. Asthmagens are substances capable of causing 
asthma. 
On July 29, 2015, we performed a small-scale air sampling and a post-shift survey 
of environmental services staff. We collected ten samples, including full-shift, task-
based, and 15-minute exposure samples, from employees’ breathing zones while they 
performed regular cleaning tasks. All samples were analyzed for the three chemicals 
found in OxyCide: hydrogen peroxide, peracetic acid, and acetic acid. All 15-minute air 
samples for acetic acid were below the NIOSH recommended short-term exposure limit 
of 15 parts per million (ppm). All 15-minute and task-based exposure air samples for 
hydrogen peroxide and peracetic acid were below the limit of detection for the instru-
ment used to detect the analyte. The limit of detection 4 µg of hydrogen peroxide per 
sample and 2 µg of peracetic acid per sample. We combined all full-shift time-weighted 
average samples and post-shift survey results from the small-scale survey on July 29 
with the results from our full environmental survey from September 8-11, 2015. 
We returned in August 2015 and administered a voluntary health and work history ques-
tionnaire to 79 environmental services staff and 84 non-environmental services staff for 
a total of 163 hospital employees. Non-environmental services staff were recruited from 
the same areas and departments of the hospital where environmental services staff were 
located. Questions addressed respiratory and dermatological symptoms, asthma and 
other diagnoses, smoking history, work history and practices, and demographic infor-
mation. 
On September 8-11, 2015, we returned to perform full-shift air sampling on environ-
mental services staff performing cleaning activities. We collected 45 full-shift air sam-
ples for hydrogen peroxide, peracetic acid, and acetic acid from the daylight, evening, 
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and night shift environmental services staff. We also administered a voluntary post-shift 
survey identical to the post-shift survey used in July 2015 to all staff who participated 
in the air sampling survey. We observed environmental services staff while they per-
formed their regular cleaning duties and noted task duration, cleaning product use and 
duration, and use of any personal protective equipment. We also assessed the ventila-
tion systems in areas of the hospital where frequent cleaning was observed. 
The highest full-shift time-weighted average exposures to hydrogen peroxide, peracetic 
acid, and acetic acid were observed in the Womancare Birth Center, Birth Center Tri-
age, Birth Center Operating Rooms, and the Medical-Surgical areas. Full-shift time-
weighted average exposure levels for hydrogen peroxide, peracetic acid, and acetic 
acid ranged from 5.5 parts per billion (ppb) – 511.4 ppb for hydrogen peroxide, 1.1 
ppb – 48.0 ppb for peracetic acid, and 6.7 ppb – 530.3 ppb for acetic acid. No full-shift 
samples were below the limit of detection. All full-shift time-weighted average air 
samples for hydrogen peroxide and acetic acid were below established U.S. occupation-
al exposure limits. The OSHA permissible exposure limit and NIOSH recommended 
exposure limit is 1 ppm for hydrogen peroxide and 10 ppm for acetic acid. To date, no 
full-shift time-weighted average occupational exposure limit for peracetic acid has been 
established in the United States. 
The most commonly reported symptoms in the health and work history questionnaire 
were nasal problems and watery eyes. Forty-two percent of health and work history 
questionnaire participants reported nasal problems and 40% of all questionnaire par-
ticipants reported watery eyes. Other commonly reported health outcomes included, 
asthma-like symptoms (28%), skin problems (19%), and wheeze (16%). Among report-
ed symptoms, some were described to be work-related, as they improved away from 
the facility. OxyCide users reported higher prevalence of work-related health outcomes 
including cough, shortness of breath, asthma-like symptoms, asthma attack, use of 
asthma medicine, asthma symptoms, use of allergy medicine, nasal problems, and skin 
problems, with wheeze and watery eyes being significantly higher in OxyCide users 
than non-users. 
Nasal and eye irritation were also the most frequently reported symptoms in the post-
shift survey of acute symptoms. We observed increases in work-related acute upper and 
lower airway symptoms in employees exposed to hydrogen peroxide, peracetic acid, 
and acetic acid vapors. Increased exposure to hydrogen peroxide, peracetic acid, and 
acetic acid was significantly associated with increases in acute nasal and eye irritation. 
For employees who participated in our air sampling survey as well as the health and 
work history questionnaire, shortness of breath on level ground was also significantly 
associated with increased exposure to hydrogen peroxide, peracetic acid, and acetic 
acid. 
We provide several means to reduce employee exposure to OxyCide. We recommend that 
management customize the use of sporicidal disinfectants like OxyCide to areas of high 
risk for healthcare-acquired infections and minimize the use of sporicidal disinfectants on 
non-critical surfaces and in non-patient areas. We also recommend that management pro-
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vide workplace accommodations for employees who develop symptoms related to the use of 
sporicidal and high-level disinfectants. Management should also ensure that all heating, ven-
tilation, and air-conditioning systems are functioning well and meet all applicable ASHRAE 
standards. Additional details and recommendations to reduce employee exposure to OxyCide 
liquids, vapors, and mists are provided in this report. 
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Introduction 
The National Institute for Occupational Safety and Health (NIOSH) received a 
confidential employee request to conduct a health hazard evaluation at a hospital. 
The request cited concerns about exposure of hospital employees to the sporicidal 
disinfectant, OxyCide, and described symptoms experienced by employees. Employee 
symptoms noted in the health hazard evaluation request included burning eyes, nose, 
and throat; runny nose; cough; headache; dizziness; nausea; nose bleeds; asthma 
exacerbation; skin burns; and rashes. 
In response to the health hazard evaluation request, we performed a walk-through 
assessment of cleaning product use at the hospital in April 2015, and informally 
interviewed employees about their cleaning product use and any related health concerns 
that they may have had. We learned that OxyCide is a one-step sporicidal disinfectant 
that consists of hydrogen peroxide (HP), peracetic acid (PAA), and acetic acid (AA). 
The product is diluted with water prior to use to a pH of 3. We observed that OxyCide 
was the main cleaning product used for all surface cleaning duties and was used 
predominantly by Environmental Services (EVS) staff. We also noted that EVS staff 
occasionally used other asthmagen-containing products, to include products containing 
ethanolamines, bleach, or quaternary ammonium compounds when cleaning glass, 
general surfaces, or bathroom surfaces. Asthmagens are substances capable of causing 
asthma. 
In July 2015, we performed a small-scale air sampling and post-shift survey of EVS 
staff. 
In August 2015, we administered a voluntary health and work history questionnaire to 
hospital employees. In September 2015, we returned to the hospital to perform a full-
shift air sampling survey and collect air samples from employees performing cleaning 
activities. 
We also administered a voluntary post-shift survey identical to the post-shift survey 
used in July 2015, to all staff who participated in the September air sampling survey. 
We observed EVS staff during both the July and September air sampling surveys, 
while they performed their regular cleaning duties and noted task duration, cleaning 
product use and duration, and use of any personal protective equipment. Additionally 
in September 2015, we performed an assessment of the heating, ventilation and air-
conditioning (HVAC) systems in place during the September 2015 survey. 
In this report, we summarize the results from our environmental survey and HVAC 
assessment. We also summarize results from the health and work history questionnaire 
and post-shift survey of acute symptoms. Additionally, we provide recommendations to 
help protect the health of employees. We previously mailed letters with interim results 
and recommendations in May and October of 2015, and April of 2016. 
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Process Description  
The hospital that is the subject of this health hazard evaluation is primarily a women’s 
hospital, and specializes in obstetrics and gynecology services for women. The hospital 
also offers medical and surgical services for both women and men. Beginning in 
March and April of 2015, OxyCide was used by EVS staff as the primary sporicidal 
disinfectant for all surface cleaning duties throughout the hospital. Environmental 
services staff were the primary housekeeping staff and performed cleaning duties and 
tasks in areas throughout the hospital. Other healthcare personnel, such as nursing 
and ancillary staff, performed occasional surface cleaning tasks, such as wiping 
down medical equipment in occupied patient rooms, as part of routine point-of-care 
cleaning activities. OxyCide was used predominantly by environmental services staff 
and nursing and ancillary staff predominantly used PDI® or bleach wipes for routine 
cleaning activities. 
Methods 
Measurement of pH of diluted product samples in April 2015
During the walkthrough assessment in April 2015, we collected bulk samples of diluted 
OxyCide product from multiple hospital units. Bulk samples of the diluted OxyCide 
product were collected to assess the Oxycide dispenser calibration. Dispenser calibration 
was assessed by measuring diluted OxyCide product pH less than 12 hours after collection. 
Samples were kept capped and stored at room temperature (21°C−23°C). Measurements of 
sample pH were taken using a pH meter (Fisher Scientific International Inc., Hampton, NH). 
Air Sampling Survey and HVAC Assessment in July and September 2015                               
We performed a pilot air sampling survey of EVS staff performing cleaning tasks on July 29, 
2015. We collected five full-shift, one task-based, and four 15-minute exposure samples from 
daylight shift employees’ breathing zones while they performed regular cleaning tasks. On 
September 8-11, 2015, we performed a larger air sampling survey and collected 45 additional 
full-shift samples on daylight, evening, and night shift employees. Thirty-six of the full-shift 
samples were collected from employees’ breathing zones while they performed their regular 
cleaning duties. Nine of the samples collected in September were moving area samples. For 
the moving area samples, we followed employees while they performed their cleaning duties 
and placed the samplers near EVS staff while they were cleaning. We also performed an 
assessment of HVAC systems in place as of September 2015. Additionally, we observed staff 
while they performed their regular cleaning duties and noted task duration, cleaning product 
use and duration, and use of any personal protective equipment. 
All air samples were analyzed for the three chemicals found in OxyCide: HP, PAA, and 
AA. HP and PAA were collected and analyzed according to the methods specified by Hecht 
et al. [2004]. AA was collected and analyzed according to the Occupational Safety and 
Health Administration (OSHA) Method PV2119 [OSHA 2003]. Results from the July and 
September 2015 air sampling surveys were combined and are summarized in the Results 
section. 
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Post-Shift Survey of Acute Symptoms in July and September 2015 
We administered a voluntary post-shift survey in July and September 2015 that asked if 
employees had experienced acute symptoms during their shift as follows: (1) burning, itchy, 
runny nose; (2) sneeze; (3) burning, itchy, watery eyes; (4) burning, dry, sore throat; (5) 
cough; (6) wheeze; (7) chest tightness; (8) shortness of breath; (9) difficulty breathing; and 
(10) dizziness. When employees reported symptoms that occurred during their work shift, 
we asked (1) if their symptom had worsened during their shift; (2) what they were doing 
when the symptom first began; and (3) if they had that symptom upon arrival at work that 
day. Work-related symptoms were defined as symptoms that occurred during the participants’
shift that were not present upon arrival at work that day. Results from the July and September 
2015 post-shift surveys were combined and are summarized in the Results section. 
Health and Work History Questionnaire 
We administered a voluntary health and work history questionnaire to hospital employees in 
August and September 2015. We aimed to offer the health and work history questionnaire 
to all EVS staff working the week of our visit, and an equal number of non-EVS staff in 
the same departments. Non-EVS staff were recruited from the same areas and departments 
of the hospital where EVS staff were located. Questions addressed eye, respiratory, and 
dermatological symptoms; asthma and other diagnoses; smoking history; work history 
and practices; and demographic information. Questions regarding respiratory symptoms 
and asthma were taken from the Third National Health and Nutrition Examination Survey 
(NHANES III) [CDC 1996] and the European Community Respiratory Health Survey 
[Burney et al. 1994; ECRHS 2014]. 
We defined asthma-like symptoms as a response of “yes” to any of the following questions 
[Grassi et al. 2003]: 
1. Are you currently taking any medicine (including inhalers, aerosols or tablets) for 
asthma? 
2. Have you had wheezing or whistling in your chest at any time in the last 12 months? 
3. Have you woken up with a feeling of tightness in your chest at any time in the last 12 
months? 
4. Have you been woken by an attack of asthma at any time in the last 12 months? 
Symptoms that improved when the employees were away from work, either on their days off 
or when they were on vacation, were considered work-related. 
Statistical Analyses 
Comparison of Pre-hire and Post-hire Onset Asthma 
The incidence densities of self-reported adult-onset asthma diagnosed by a physician 
before and after hire were estimated using birth date, hire date, and diagnosis date. Asthma 
incidence density before hire was calculated by adding the number of adult-onset asthma 
diagnoses that occurred before hire and dividing by the total number of participants’ adult 
years at risk before hire. Asthma incidence density after hire was calculated by adding the 
number of adult-onset asthma diagnoses that occurred after hire and dividing by the total 
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number of participants’ years at risk after hire. An incidence ratio was calculated using 
Poisson regression. 
Comparison to U.S. Population 
We compared the observed prevalence of symptoms and diagnoses among participants to 
expected values for the U.S. adult population obtained from NHANES III. To compare 
the survey participants to the U.S. adult population, we calculated Standardized Morbidity 
Ratios (SMRs) using indirect standardization for race (White, Black, or Mexican-American), 
sex, age (range: 17 to 39 years or ≥ 40 years), and cigarette smoking status (ever vs. never 
smoker) [CDC 1996]. 
Health Outcomes and Exposure Metrics Associations: EVS vs. Non-EVS and OxyCide Use 
vs. Non-OxyCide Use
Statistical significance was assessed using t-test for continuous variables and chi-square 
test for categorical variables. We used Fisher’s exact test when cell sizes were less than 5. 
We considered two-sided p ≤ 0.05 to be statistically significant.  Prevalence ratios were 
calculated for symptoms and diagnoses using Poisson regression. 
Associations Between Acute and Chronic Health Outcomes and Exposure Metrics: Individual 
Level Exposure
We explored associations between employee’s personal exposure to HP, PAA, and AA
and work-related acute symptoms and symptoms occurring in the last 12 months using 
log-binomial regression. We used the American Conference of Governmental Industrial 
Hygienists’ (ACGIH) Additive Mixture Formula to create mixture exposure groups for the 
total mixture (TM) of HP, PAA, and AA as well as the oxidant exposure mixture (OM) of HP
and PAA [ACGIH 2016]. Measured ppm concentrations of HP and AA were divided by their 
established OSHA Permissible Exposure Limit (PEL) and NIOSH Recommended Exposure 
Limit (REL) of 1 ppm for HP and 10 ppm for AA (Equations 1 and 2). Measured ppm 
concentrations of PAA were divided by 0.2 ppm, the occupational exposure limit proposed by 
multiple researchers [Gagnaire et al. 2002; Pechacek et al. 2015; Pacenti et al. 2010]. TM and 





where [HP], [PAA], and [AA] represent the measured full-shift TWA concentrations for HP, 
PAA, and AA. The summed values from the additive formula were divided into tertiles to 
create TM and OM exposure variables with low, medium, and high exposure categories. TM 
and OM exposure variables were used for exposure and health outcome analyses. 
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SAS PROC GENMOD’s log-binomial regression was used to calculate prevalence ratios and 
95% confidence intervals for acute and chronic symptoms associated with individual level 
exposure. TM exposure was analyzed as continuous or categorical, with categories defined 
as (1) low = less than 0.088, (2) medium = 0.088 to 0.236, or (3) high = greater than 0.236. 
OM exposure was analyzed as continuous or categorical with categories defined as (1) low = 
less than 0.08, (2) medium = 0.080 to 0.218, and (3) greater than 0.218. When the GENMOD 
models did not converge, Fischer’s exact test was used to compare symptom prevalence 
among the exposure categories. Age, gender, and smoking status were initially included in 
the GENMOD log-binomial regression models; however, the models did not converge. The 
LOGISTIC procedure in SAS was used to examine associations of age, gender, or smoking 
status with eye, upper and lower airway symptoms. 
We also explored associations between work-related acute symptoms and age, gender, tenure, 
smoking status, and use of cleaning products containing known asthmagens using logistic 
regression. Asthmagen-containing cleaning products were defined as products containing 
quaternary ammonium compounds, bleach, or ethanolamines. Use of quaternary ammonium 
compounds, bleach, or ethanolamines was recorded from our direct observations of EVS staff 
while they performed their regular cleaning duties. We explored associations between work-
related symptoms and use of products containing (1) quaternary ammonium compounds; (2) 
bleach; or (3) ethanolamines. We also assessed associations between work-related symptoms 
and use of a combination of these products throughout the work day by using an asthmagen 
index value. The asthmagen index value (0-3) was determined by adding the number of 
asthmagen products that an employee was observed using on the day of air sampling. 
Associations Between Acute and Chronic Health Outcomes and Exposure Metrics: 
Departmental Level Exposure 
We also calculated the average TM exposure for each of the nine hospital departments where 
air sampling was performed. Eighty-five survey participants worked on a department where 
air sampling was performed. We assessed associations between average departmental TM 
exposure and symptoms reported by staff. SAS PROC GENMOD’s Poisson regression was 
used to calculate unadjusted prevalence ratios and 95% confidence intervals for symptoms 
associated with department level exposure. TM exposure was analyzed as a categorical 
variable by dividing each of the nine departments into three categories: high, medium 
and low TM exposure, with three departments in each category. SMRs for symptoms were 
calculated among individuals who worked on the department with the highest TM exposure. 
Comparison of Post-shift Survey and Health and Work History Questionnaire 
We summarized the prevalence of symptoms reported by EVS staff in both the post-shift 
acute symptom survey and health and work history questionnaire. Symptoms that were asked 
about in both the post-shift acute symptom survey and work history questionnaire included: 
nasal irritation, eye irritation, cough, wheeze, shortness of breath, and chest tightness. 
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Results 
Major findings in relation to EVS staff, OxyCide use, and related exposure measurements 
are presented below. Supplemental analyses and findings from the site visits are presented 
in Appendix A. In general, we observed that Oxycide was the main cleaning product used 
for all surface cleaning duties. We noted that some hospital employees had the impression 
that because the chemicals contained in OxyCide are similar to chemicals found in common 
household products, there is little health risk from exposure to this product. We also noted 
that OxyCide was formerly used as a spray cleaner by some staff in some units. Several 
employees reported previous Oxycide splashes and spills that resulted in skin or eye 
irritation. Some environmental services staff reported that there was no ventilation in some 
of the bathrooms that they cleaned. Several staff mentioned that their symptoms were worse 
when performing cleaning duties in the bathrooms, especially in the shower stalls. 
During our visits, we observed that EVS staff used automated dispensers designed to dilute 
the concentrated OxyCide product to its at-use pH of 3. We made pH measurements of 
the diluted OxyCide product that ranged from 2.85-4.86. The product’s safety data sheet 
indicates that OxyCide should be diluted to a pH of 3. We observed staff using the automated 
dispensers to pour OxyCide directly into plastic bottles. The plastic bottles were then used 
to pour OxyCide into open faced buckets that housed a roll of disposable cloth wipes. We 
observed that nitrile gloves were used routinely when working with cleaning products. Staff 
occasionally chose to also wear goggles or a surgical mask when dispensing or working with 
cleaning products. 
Summary of July 2015 and September 2015 Air Sampling Results and Post-Shift Survey of 
Acute Symptoms 
Full shift air sample results ranged from 6 parts per billion (ppb) to 511 ppb for HP, 7 ppb 
to 530 ppb for AA, and 1 ppb to 48 ppb for PAA (Figure 1). For AA, 15-minute air samples 
ranged from 442 ppb to 456 ppb. All 15-minute and task-based exposure air samples for HP
and PAA were below the limit of detection for the instrument used to detect the analyte. The 
limit of detection was 4 µg of hydrogen peroxide per sample and 2 µg of PAA per sample. 
The median exposure levels observed were 72 ppb for HP, 14 ppb for PAA, and 124 ppb for 
AA. The highest personal exposures were observed for employees in the Womancare Birth 
Center (WCBC). The average air concentrations measured on employees in each sampled 
unit are provided in Table 1. The highest summed values for HP, PAA, and AA, and HP and 
PAA exposures were observed in the Womancare Birth Center, Birth Center Triage, Birth 
Center Operating Rooms, and the Medical Surgical areas. 














Figure 1. Box-plots of full-shift time-weighted average exposure levels of hydrogen peroxide, peracetic 
acid, and acetic acid, NIOSH survey, July and September 2015. Note: ppb=parts per billion. The box-
plots illustrate each quartile with the lowest quartile shown as the line and hatch mark below the box,
the second and third quartiles indicated by the shaded box, and the highest quartile indicated by the line
and hatch mark above the boxes. The line within each box indicates the median air sample concentration. 
Outlier air samples are denoted by dots. The OSHA PEL and NIOSH REL is 1000 ppb (1 ppm) for
hydrogen peroxide and 10,000 ppb (10 ppm) for acetic acid. 
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Currently, there is no OSHA PEL or NIOSH REL for exposure to the mixture of HP, PAA, 
and AA. Most exposure limit values are created for exposure to a single chemical substance 
[ACGIH 2016]. There are occupational exposure limits for exposure to HP or AA. The 
OSHA PEL and NIOSH REL is one ppm (1000 ppb) for exposure to HP and 10 ppm (10,000 
ppb) for exposure to AA. All measurements for HP and AA were below their respective 
OSHA PELs and NIOSH RELs [NIOSH 2010] for exposure to HP or AA alone. There is 
currently no OSHA PEL or NIOSH REL for occupational exposure to PAA, however, several 
research groups have suggested 0.2 ppm as an exposure limit [Gagnaire et al. 2002; Pechacek 
et al. 2015; Pacenti et al. 2010]. ACGIH developed a mixture formula that can be used 
when multiple chemical exposures occur simultaneously and have similar biological effects 
[ACGIH 2016]. The ACGIH mixture formula was used to create the TM and OM used for 
the results presented below. HP and PAA are strong oxidants, and their mixture is listed as an 
asthmagen and respiratory sensitizer by the Association of Occupational and Environmental 
Clinics [AOEC 2015]. Asthmagens are substances that can cause asthma. Respiratory 
sensitizers are materials that can cause an immune response and adverse respiratory effects, 
even at low levels of exposure. 
Mucous membrane irritation (burning eyes and/or burning nose) was reported by 64% (n = 
32/50) of post-shift survey participants, and 84% (n = 27/32) of these participants reported 
symptom onset while cleaning. Lower airway symptoms such as cough, wheeze, chest 
tightness, shortness of breath or difficulty breathing were reported in 34% (n = 17/50) of 
post-shift survey participants; of whom 88% (n = 15/17) reported symptom onset during 
cleaning activities. Symptom prevalence in low, medium, and high TM and OM exposure 
groups can be seen in Table 2. Prevalence of work-related acute eye and upper airway 
symptoms were similar in the TM and OM exposure groups (Table 2). 
In the highest TM exposure group, 1.4–6.5-fold more participants reported work-related 
nasal irritation, eye irritation, sneeze, and burning, dry or sore throat compared to the lowest 
exposure group. In the highest TM exposure group, 87.5% of participants reported work-
related nasal irritation; 81.3%, reported eye irritation; 37.5%, reported sneeze, and 25.0% of 
participants reported burning dry or sore throat. 
Age, smoking status, gender, and use of products containing other asthmagens were not 
significantly associated with acute eye, upper airway, or lower airway symptoms reported 
in the post-shift survey and were not included in our models. Nasal and eye irritation were 
significantly associated with increased TM and OM exposure. Both the highest TM and 
OM exposure groups had 3.5 fold higher prevalence of nasal irritation symptoms when 
compared to the lowest TM and OM exposure groups (Figure 2). Eye irritation prevalence 
was similar for both the highest TM and OM exposure groups as well, with 6.4–6.5 fold 
higher prevalence, when compared to the lowest TM and OM exposure groups (Figure 2). 
An exposure-response relationship was observed for sneeze and throat symptoms as well, 
although the increases were not statistically significant. Employees in the highest TM mixture 
exposure group had 3.0 (p = 0.14) and 2.0 (p = 0.38) fold higher prevalence of sneeze 
and burning throat, respectively, when compared to the lowest exposure group (Figure 2). 
Employees in the highest OM exposure group had 5.3 (p=0.11) and 1.4 (p=0.6) fold higher 
prevalence of sneeze and burning throat, respectively, when compared to the lowest exposure 
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group. 
The number of employees that reported lower airway symptoms during their shift was 
too small to calculate prevalence ratios using the GENMOD log-binomial procedure in 
SAS. No employees in the lowest TM or OM exposure groups reported acute work-related 
(1) wheeze; (2) chest tightness; (3) shortness of breath; or (4) difficulty breathing. In 
comparison, employees exposed to mixture levels in the medium and highest TM and OM 
exposure groups (n = 33) reported (1) wheeze (n = 3, 9%); (2) chest tightness (n = 2, 6%); (3) 
shortness of breath (n = 3, 9%); and difficulty breathing (n = 2, 6%) (Table 2). Despite these 
trends, Fisher’s Exact Test did not indicate any significant associations. 
We also explored associations between exposure to HP, PAA, or AA and acute symptoms 
occurring during the work shift using logistic regression (Appendix A, Table A4). Mucous 
membrane irritation symptoms, specifically burning itchy, runny nose, sneeze, and burning, 
itchy, watery eyes, were statistically significantly positively associated with HP, AA, and 
PAA exposure, indicating an increase in symptoms with increasing exposure. We also 
explored associations between age, gender, tenure, smoking status, and use of cleaning 
products containing known asthmagens and work-related acute symptoms using logistic 
regression. No associations were found. 
Summary of Chronic Upper and Lower Airway Symptoms in Participants in the Air 
Sampling, Post-shift Survey, and Health and Work History Questionnaire 
Thirty-five employees participated in all three components of our employee evaluation: the 
personal air sampling, the post-shift survey of acute symptoms, and the health and work 
history questionnaire. 
On the health and work history questionnaire, 57.1% of these 35 participants reported chronic 
nasal problems and 51.4% reported watery eyes in the last 12 months (Table 2). Regarding 
chronic lower respiratory symptoms, 5.7% of these participants reported cough; 22.9% 
reported usual shortness of breath on level ground; 14.3% reported wheeze in the previous 12 
months; and 17.1% reported awaken from chest tightness in the previous 12 months. 
The highest TM and OM exposure group for these 35 participants had 3.1 and 3.7 fold higher 
prevalence of shortness of breath on level ground when compared to the lowest TM and OM 
exposure groups (Table 3). Shortness of breath on level ground was significantly associated 
with increased TM exposure (p = 0.026) and OM exposure (p = 0.017). Prevalence of wheeze 
in the last 12 months was 2.3-2.8 fold higher in the highest TM and OM exposure groups, 
when compared to the lowest exposure group (Table 3). Age, smoking status, gender, and 
use of products containing other asthmagens were not significantly associated with chronic 
eye, upper airway or lower airway symptoms reported in the health and work history 
questionnaire and were not included in the analyses presented here. 
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Table 2. Acute and chronic symptom prevalence, by total mixture and oxidant mixture exposure 








(n=50) Low Medium High Low Medium High 
Nasal irritation*† 52.0 25.0 47.1 87.5 25.0 50.0 86.7 
Eye irritation*† 44.0 12.5 41.2 81.3 12.5 44.4 80.0 
Sneeze 22.0 12.5 17.7 37.5 6.3 27.8 33.3 
Burning, dry, sore throat 18.0 12.5 17.6 25.0 18.8 11.1 26.7 
Cough 20.0 18.8 23.4 18.8 18.8 22.2 20.0 
Wheeze 6.0 0 11.8 6.3 0 11.1 6.7 
Chest tightness 4.0 0 5.9 6.3 0 5.6 6.7 
Shortness of breath 6.0 0 5.9 12.5 0 5.6 13.3 
Difficulty breathing 4.0 0 11.8 0 0 11.1 0 




(n=35) Low Medium High Low Medium High 
Nasal problems,
previous 12 months 57.1 40.0 50.0 76.9 45.5 50.0 75.0 
Watery eyes, previous 
12 months 51.4 40.0 41.7 69.2 45.5 41.7 66.7 
Usual cough 5.7 10.0 0 7.7 9.1 0 8.3 
Shortness of Breath on 
level ground† 22.9 10.0 25.0 30.8 9.1 25.0 33.3 
Wheeze, previous 12
months 14.3 10.0 8.3 23.1 9.1 8.3 25.0 
Awaken from chest 
tightness, previous 12 17.1 20.0 8.3 23.1 27.3 8.3 16.7 
months 
Asthma medication use 8.6 10.0 0 15.4 9.1 0 16.7 
Asthma-like symptoms 28.6 30.0 16.7 38.5 36.4 16.7 33.3 
Note: TM=total mixture (hydrogen peroxide, peracetic acid, and acetic acid); OM=oxidant mixture 
(hydrogen peroxide and peracetic acid). 
*Indicates symptoms significantly positively associated with increased exposure to the total mixture (p ≤ 
0.05).
†Indicates symptoms significantly positively associated with increased exposure to the oxidant mixture (p 
≤ 0.05). 
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Table 3. Acute and chronic symptom prevalence ratios relative to the low exposure group, by total 
mixture and oxidant mixture exposure group, July-September 2015 
TM Prevalence Ratio (95% CI) OM Prevalence  Ratio (95% CI) 
Acute Symptom 
(post-shift survey) Medium High Medium High 
Nasal irritation*† 1.88 (0.70-5.05) 3.50 (1.47-8.34) 2.00 (0.76-5.26) 3.47 (1.45-8.29) 
Eye irritation*† 3.29 (0.80-13.56) 6.50 (1.74-24.27) 3.56 (0.88-14.35) 6.40 (1.71-23.98) 
Sneeze 1.41 (0.27-7.38) 3.00 (0.71-12.69) 4.44 (0.58-34.14) 5.33 (0.70-40.54) 
Burning, dry, sore throat 1.41 (0.27-7.38) 2.00 (0.42-9.42) 0.59 (0.11-3.11) 1.42 (0.38-5.33) 
Chronic Symptom   
(health and work history
questionnaire) 
Medium High Medium High 
Nasal problems, previous
12 months 1.25 (0.49-3.22) 1.92 (0.85-4.35) 1.10 (0.47-2.60) 1.65 (0.80-3.41) 
Watery eyes, previous 12 
months 1.04 (0.38-2.87) 1.73 (0.75-4.01) 0.92 (0.36-2.33) 1.47 (0.69-3.14) 
Usual cough ̶ 0.77 (0.05-10.84) ̶ 0.92 (0.06-12.95) 
Shortness of Breath on 
level ground† 2.50 (0.31-20.45) 3.08 (0.40-23.44) 2.75 (0.33-22.69) 3.67 (0.48-28.00) 
Wheeze, previous 12
months 0.83 (0.06-11.70) 2.31 (0.28-18.99) 0.92 (0.06-12.95) 2.75 (0.33-22.69) 
Awaken from chest 
tightness, previous 12 0.42 (0.04-3.95) 1.15 (0.24-5.65) 0.31 (0.04-2.52) 0.61 (0.12-3.00)
months 
Asthma medication use ̶ 1.54 (0.16-14.66) ̶ 1.83 (0.19-17.51) 
Asthma-like symptoms 0.56 (0.11-2.70) 1.28 (0.40-4.13) 0.46 (0.10-2.03) 0.92 (0.30-2.81) 
Note: TM=total mixture (hydrogen peroxide, peracetic acid, and acetic acid); OM=oxidant mixture (hydrogen 
peroxide, and peracetic acid). Prevalence ratios were calculated for the medium and high exposure groups, 
compared to the low exposure group. Cough, wheeze, chest tightness, shortness of breath, difficulty breathing, 
and dizziness reported in the post-shift survey were too few to calculate prevalence ratios using PROC­
GENMOD in SAS and are not included in this table. 
*Indicates symptoms significantly positively associated with increased exposure to the total mixture (p ≤ 0.05). 
†Indicates symptoms significantly positively associated with increased exposure to the oxidant mixture (p ≤ 0.05). 
̶ Number of employees that reported symptoms was too small to calculate prevalence ratios using the GENMOD
log-binomial procedure in SAS. 
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Figure 2. Prevalence ratios and 95% confidence intervals for eye and upper airway symptoms reported 
during as occurring during employees’ shift in the medium and high compared to low total mixture 
(hydrogen peroxide, peracetic acid, and acetic acid) and oxidant mixture (hydrogen peroxide and 
peracetic acid) exposure groups, July and September 2015. *signifies symptoms significantly positively 
associated with the highest exposure group (p-value ≤ 0.05). 
Heating, Ventilation, and Air-conditioning System Evaluation                                                 
All of the air-handling units and associated ductwork appeared to be in good working order 
and well maintained. We assessed the ventilation systems present in 29 areas in the hospital, 
including rooms in the following units: 2700, 2800, 3100, 3200, 3700, 3800, 4100, 4800, 
5300, 5800, Neonatal Intensive Care Unit, and Womancare Birth Center. We observed that 
the EVS cleaning closets in the 3100 and 5300 units had no supply air and no return flow. 
Participant Demographics and Responses to Health and Work History Questionnaire           
A total of 163 current employees, including 79 EVS staff and 84 non-EVS staff, completed 
the health and work history questionnaire. The participation rate among EVS staff who were 
working on the days of the health and work history questionnaire administration was 77%. 
Table 4 describes the job groups of non-EVS participants. 
The median age of EVS participants was 45 years (range: 20 years to 67 years) compared 
to 40 years among non-EVS participants (range: 19 years to 67 years) (Table 5). A higher 
proportion of EVS participants (49%) than non-EVS participants (13%) were male. The 
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majority of non-EVS staff were white (85%); whereas, the majority of EVS participants were 
black (59%). Tenure and smoking history was similar between the two groups. 
Although most EVS staff were OxyCide users, and most non-EVS staff did not use OxyCide, 
11 (14%) EVS staff indicated that they did not use OxyCide, while 10 (12%) non-EVS staff 
members indicated that they used OxyCide. 
Table 4.  Job groups of 84 non-EVS questionnaire participants, August – September 2015 
Job Group N (% of total non-EVS) 
Nursing staff* 27 (32%) 
Other patient care staff† 25 (30%) 
Administrative staff‡ 13 (15%) 
Other hospital staff§ 19 (23%) 
Note: EVS=environmental services staff 
* Nursing Staff includes Staff Nurses, Registered Nurses, Nurse Coordinators, 
Professional Staff Nurses, Resource Nurses, and Collaborative Practice Nurses.
 † Other Patient Care Staff includes Patient Care Technicians, Certified Nursing Assistants, Clinicians, 
Respiratory Therapists, Medical Assistants, Nurse Practitioners, Surgical Technicians, Surgical 
Technologists and Ultrasound Technicians. 
‡ Administrative Staff includes Patient Access Staff, Business Managers, Health Unit Coordinators, 
Administrative Assistants, Unit Directors, and Unit Secretaries.
§ Other Hospital Staff includes Pharmacists, Cooks, Pharmacy Technicians, Laboratory staff, Registered 
Dieticians, Room Service Attendants, Patient Transporters, Sanitation Aides, and Valet Parking 
Attendants. 
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All participants’ responses to questions about symptoms and self-reported diagnoses can be 
seen in Table 6. The most commonly reported symptoms were nasal problems and watery 
eyes. Nasal problems were reported by 42%, and watery eyes were reported by 40% of all 
participants. Other commonly reported health outcomes included asthma-like symptoms 
(28%), skin problems (19%) and wheeze (16%). Among reported symptoms, some were 
described to be work-related, as they improved away from the facility. The prevalence of 
work-related symptoms ranged from 2% to 18%. 
Table 6.  Symptoms and self-reported diagnoses of all questionnaire participants (N=163), 
August-September 2015 
Health Outcome All Participants, n (%) Work Related*, n (%) 
Cough 9 (6%) 4 (2%) 
Shortness of breath 21 (13%) 7 (4%) 
Wheeze† 26 (16%) 6 (4%) 
Chest tightness† 18 (11%) 4 (2%) 
Asthma attack† 8 (5%) 4 (2%) 
Asthma medicine 18 (11%) 6 (4%) 
Allergy medicine 48 (29%) 9 (6%) 
Asthma-like symptoms§ 46 (28%) 16 (10%) 
Nasal problems† 68 (42%) 29 (18%) 
Watery eyes† 65 (40%) 31 (18%) 
Skin problems† 31 (19%) 19 (11%) 
Asthma
 Ever 32 (20%)
 Current 23 (14%) 
Nasal allergies 37 (23%) 
*Work-related symptoms were defined as symptoms that improved away from the facility, either on days 
off or on vacation. 
† In the past 12 months
‡ Asthma-like symptoms were defined as current use of asthma medicine and/or one or more of the 
following symptoms in the last 12 months: wheezing or whistling in the chest, awakening with a feeling of 
chest tightness, or attack of asthma. 
Comparison of EVS and Non-EVS Staff 
Physician Diagnosed Asthma Reported by EVS and Non-EVS Staff
There was no significant difference between EVS and non-EVS staff with regard to ever 
having a physician’s diagnosis of asthma or current asthma (Appendix A, Table A1). The 
prevalence of ever having a physician diagnosis of asthma among EVS staff participants was 
2.1 times (95% CI = 1.2, 3.7) that of the expected prevalence for the U.S. adult population, 
while the prevalence of current asthma among EVS staff was 2.3 times (95% CI = 1.2, 4.3) 
the expected prevalence for the U.S. adult population. Similarly, among non-EVS staff, these 
prevalences were higher than the expected values for the U.S. adult population; 2.6 times 
(95% CI = 1.6, 4.1) higher for ever-asthma, and 2.4 times (95% CI = 1.3, 4.2) higher for 
current asthma. 
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Among the 32 participants who reported ever having a physician diagnosis of asthma, 
approximately double the percentage of EVS staff (62%) compared to non-EVS staff (32%) 
indicated that something at work brings on or worsens their asthma; the prevalence of asthma 
brought on or made worse by work for EVS and non-EVS staff is shown in Figure 4. Among 
the 14 employees that said something at work brings on or worsens their asthma, 36% 
indicated that OxyCide brought on or made their asthma worse. 
Symptoms and Medication Use Reported by EVS Staff 
EVS staff reported higher prevalences of work-related health outcomes including shortness 
of breath, asthma-like symptoms, use of asthma medicine, use of allergy medicine, nasal 
problems, and skin problems, with statistically significant higher reports of wheeze and 
watery eyes (Figure 3; Appendix A, Table A1). In addition, EVS staff had significantly higher 
prevalence of nasal problems and watery eyes brought on or made worse by something at 
work (Figure 4). Among the 32 employees who said that something at work brought on or 
made their nasal problems worse, 56% specified OxyCide. Seventy-one percent of those who 
reported that something at work brought on or made their watery eye symptoms worse at 
work, also specified OxyCide. Among EVS staff reporting skin problems, 75% reported that 
something at work brought on or made this symptom worse, compared to 42% of non-EVS 
staff. Fifty-three percent of staff who reported that something at work brought on or made 
their skin problems worse specified that OxyCide brought on or made their skin problems 
worse. 
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Figure 3. Prevalence of health outcomes brought on or made worse by something at work by EVS vs. non-EVS staff, 
August-September 2015. Percentages reflect the number of participants who reported a health outcome and indicated if 
it was brought on or made worse by something at work. 
Note: EVS=environmental services staff  
* Statistically significant differences (p ≤ 0.05) are indicated by an asterisk next to the name of the symptom.  
† Indicates all symptoms specific to the last 12 months 
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Comparison of OxyCide Users and Non-users 
In general, the comparisons between Oxycide users and non-users showed similar patterns to 
those described above for EVS staff and non-EVS staff. 
Physician Diagnosed Asthma Reported by OxyCide Users and Non-Users 
There was no significant difference between OxyCide users and non-users with regard to ever 
having a physician’s diagnosis of asthma or current asthma. Both groups had higher than 
expected asthma prevalence when compared to the U.S. population (Appendix A, Table A2). 
Other Health Outcomes Reported by OxyCide Users and Non-Users 
OxyCide users reported higher prevalence of work-related health outcomes including cough, 
shortness of breath, asthma-like symptoms, asthma attack, use of asthma medicine, asthma 
symptoms, use of allergy medicine, nasal problems, and skin problems, with wheeze and 
watery eyes being significantly higher (Appendix A, Figure A1). 
Associations with department-level exposures 
The department with the highest average TM was the WCBC. Prevalence ratios comparing 
the WCBC to the 3 departments with the lowest average TMs (2700/2800, Outpatient Clinic, 
and 4100) were calculated for wheeze, chest tightness, nasal problems, watery eyes and 
asthma-like symptoms and can be seen in Figure 5. Statistically significant results were 
found for watery eyes in the WCBC (PR= 2.88, 95% CI=1.18-7.05) and for the three highest 
units (WCBC, 5300, and NICU) with high ACGIH mixture concentrations (PR= 2.58, 95% 
CI=1.07-6.26) when compared to departments with low concentrations. When compared to 
all other departments, there were no significant differences among the survey participants 
in the WCBC with regard to sex, race, smoking status or those working in EVS.  However, 
participants on the WCBC unit were significantly younger, with an average age of 37 and 
workers on all other units with an average age of 44 (t-test, p=0.0169). 
We compared the prevalence of shortness of breath, cough, wheeze, watery eyes and asthma 
diagnosis among workers in the WCBC compared to the U.S. population.  The prevalence 
of watery eyes (SMR= 1.70, 95% CI= 1.06-2.72), lifetime asthma diagnosis (SMR=2.50, 
95% CI=1.07-5.85), and current asthma (SMR= 3.47, 95% CI= 1.48-8.13) was significantly 
higher than expected when compared to the U.S. population. Watery eyes and current 
asthma among workers in all other departments was not significantly higher than expected. 
However, lifetime asthma diagnosis was significantly higher than expected (SMR=2.52, 95% 
CI=1.41-4.51) in these other departments. 
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Figure 5. Prevalence ratios for symptoms in the Labor and Delivery Department (WCBC), 3 departments 
with the highest average TM (WCBC, 5300, NICU) and 3 departments with medium TMs (5800, 
3700/3800, 4800) compared to the 3 departments with the lowest average TMs (4100, Outpatient Clinic, 
2700/2800). Statistically significant results are noted with an (*). All symptoms specific to the last 12 
months are noted with an (†). Asthma-like symptoms (§) were defined as current use of asthma medicine 
and/or one or more of the following symptoms in the last 12 months: wheezing or whistling in the chest, 
awakening with a feeling of chest tightness, or attack of asthma. 
We compared the prevalence of shortness of breath, cough, wheeze, watery eyes and asthma 
diagnosis among employees in the WCBC to the U.S. population.  The prevalence of watery 
eyes (SMR= 1.70, CI= 1.06-2.72), lifetime asthma diagnosis (SMR=2.50, CI=1.07-5.85), and 
current asthma (SMR= 3.47, CI= 1.48-8.13) were significantly higher than expected when 
compared to the U.S. population. Watery eyes and current asthma among employees in all 
other departments were not significantly higher than expected. However, lifetime asthma 
diagnosis was significantly higher than expected (SMR=2.52, CI=1.41-4.51) in these other 
departments. 
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Discussion 
Overall, we observed a higher prevalence of work-related health outcomes in EVS staff, 
when compared to non-EVS staff. EVS staff reported a higher prevalence of work-related 
shortness of breath, asthma-like symptoms, use of asthma medication, use of allergy medi-
cine, nasal problems, and skin problems. In addition, EVS staff had significantly higher 
prevalence of work-related nasal problems and watery eyes (Figure 4). Among employees 
who said that something at work brought on or made their nasal problems worse, approxi-
mately half (56%) specified OxyCide. Almost three-quarters (71%) of staff who reported that 
something at work brought on or made their watery eye symptoms worse at work also speci-
fied OxyCide. When compared to non-EVS staff, EVS staff had almost twice the prevalence 
(75% EVS staff, 42% non-EVS staff) of skin problems that were brought on or made worse at 
work. Of staff who reported that something at work brought on or made their skin problems 
worse, 53% specified OxyCide. Work-related watery eyes and wheeze were significantly 
more common among EVS staff when compared to non-EVS staff. 
EVS staff using OxyCide reported acute and chronic symptoms. Symptoms were associated 
with exposure to the mixture of vapors from Oxycide. The highest Oxycide vapor exposure 
group (TM) had 3.5 and 6.5 fold increases in acute nasal and eye irritation, respectively (Fig-
ure 2). Increases in exposure to the vapors from Oxycide were also significantly associated 
with chronic shortness of breath on level ground. The highest TM exposure group had 3.1 
fold higher prevalence of shortness of breath. The highest TM exposure group also had 2.3 
fold higher prevalence of wheeze in the last 12 months, when compared to the lowest expo-
sure group, albeit this difference was not significant (Table 3). 
Our results suggest that exposure to Oxycide contributed to acute eye and upper airway 
symptoms, as well as shortness of breath, in hospital cleaning employees using Oxycide. The 
results of our evaluation are consistent with previous studies that have reported an increased 
risk for dermatitis, chronic bronchitis and work-related rhinitis and asthma in workers ex-
posed to cleaning and disinfectant chemicals [Maçãira et al. 2007; Rosenman et al. 2003; 
Vizcaya et al. 2011; Charles, Loomis, and Demissie 2009]. We observed health effects in 
cleaning staff at exposure levels below established occupational exposure limits. Because 
both HP and PAA are strong oxidants, the mixture of HP and PAA potentially contributed 
to the airway symptoms reported by cleaning staff, at the relatively low levels of measured 
exposures. 
We observed that some hospital employees were informed and had the impression that 
because the chemicals contained in OxyCide are similar to common household products, 
there is little health risk from exposure. The 2008 HICPAC Guideline recommends that each 
worker be informed of the possible health effect(s) of his or her exposure to chemicals. Spe-
cifically, employees should be educated on the documented health risks from exposure to HP, 
AA and PAA, as well as chemicals found in other cleaners at the hospital. This information 
should be consistent with Safety Data Sheets, Environmental Protection Agency regulations, 
and OSHA requirements and identify areas and tasks where there is the potential for expo-
sure. In 2015, Oxycide was listed as an asthmagen, or a substance that causes asthma, by the 
Association of Occupational and Environmental Clinics (AOEC) [AOEC 2015]. 
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We recommend that company management pursue the actions listed below to reduce em-
ployee exposure to the sporicidal disinfectant, Oxycide. Because employees are most familiar 
with the areas and tasks involved, we recommend that management involve employees that 
perform the work duties in each respective area when enacting any actions described below. 
Labor-management health and safety meetings are an opportune environment to discuss 
department specific recommendations and develop an action plan. Many of our recommen-
dations come from the CDC’s Healthcare Infection Control Practices Advisory Committee 
(HICPAC), which developed a Guideline for Disinfection and Sterilization in Healthcare 
Facilities in 2008 [CDC 2008]. This Guideline acknowledges that occupational diseases 
among cleaning personnel have been associated with disinfectant use at levels below OSHA
or NIOSH exposure limits. HICPAC recommends that controls be used to minimize exposure 
to disinfectants, including elimination or substitution of the chemical, engineering or ad-
ministrative controls, or the use of personal protective equipment. Additional information is 
provided in the Recommendations section, below. 
Conclusions 
In summary, acute eye symptoms and upper and lower respiratory symptoms were common 
in EVS staff during their shifts. EVS staff using Oxycide, a sporicidal disinfectant consist-
ing of HP, PAA, and AA, reported acute eye and airway symptoms, as well as chronic airway 
symptoms at low levels of measured exposures. Increased exposure to HP, PAA, and AA was 
significantly associated with increases in work-shift acute nasal and eye irritation and short-
ness of breath on level ground. All full-shift TWA air samples for HP and AA were below es-
tablished occupational exposure limits. Whether analyzed by EVS staff versus non-EVS staff 
or by OxyCide use versus non-OxyCide use, we found higher prevalences of work-related 
symptoms in the potentially exposed group versus the comparison group. We also found posi-
tive associations between exposure measurements related to OxyCide use and some health 
effects. Our results indicate a need to (1) monitor respiratory and eye symptoms in hospital 
cleaning staff using cleaning products containing HP, PAA, and AA, and (2) use a combina-
tion of engineering and administrative controls to reduce employee exposures. 
Recommendations 
Our recommendations are based on an approach known as the hierarchy of controls. This 
approach groups actions by how effective they are at removing or reducing hazards. In most 
cases, the primary approach is to eliminate hazardous materials or processes, and to install 
engineering controls to reduce exposure or shield employees. Administrative measures and 
personal protective equipment may be needed until such engineering controls are in place, or 
if engineering controls are not effective or feasible. Hospital management has already taken 
some steps to minimize employee exposure to OxyCide and address employee concerns. 
Below, we provide additional recommendations in the continued effort to improve employee 
health and safety.  





Elimination or Substitution 
A primary approach to minimizing exposure risk is to eliminate hazardous materials or 
processes. Sporicidal disinfectants are an important part of reducing healthcare-acquired 
infections. However, the choice to use sporicidal disinfectants in specific areas of the 
hospital should be prudent and reflect the level of risk of a healthcare-acquired infection. 
We observed the sporicidal disinfectant, OxyCide, being used by cleaning staff on surfaces 
throughout the hospital, including surfaces in non-patient areas. HICPAC provides 
recommendations for when and where sterilization with sporicides, versus disinfection 
with high- and low-level disinfectants, should occur in healthcare facilities [CDC 2008]. 
HICPAC states that HP and PAA can be used as high-level disinfectants for semicritical items 
that come into contact with mucus membranes or non-intact skin like respiratory therapy 
and anesthesia equipment, and some endoscopes [CDC 2008]. Surfaces that may come 
into contact with non-intact skin for short periods of time, like bed side rails, are typically 
considered noncritical surfaces and may be disinfected with phenolic, iodophors, alcohols, or 
chlorine compounds [CDC 2008]. Exposure to vapors containing HP, PAA, and AA could be 
reduced by substituting intermediate or low-level disinfectants for OxyCide when cleaning 
and disinfecting noncritical surfaces like bed rails, patient furniture, and bedside tables, and 
when cleaning surfaces in non-patient areas. HICPAC states that detergent and water are 
adequate for cleaning surfaces in non-patient care areas. We recommend that OxyCide not be 
used in non-patient care areas such as public bathrooms or administrative offices. 
Engineering Controls 
Engineering controls can reduce employees’ exposures by lowering air concentrations 
with increased ventilation or by placing a barrier between the hazard and the employee. 
Engineering controls protect employees effectively without placing primary responsibility of 
implementation on the employee. 
1. We recommend that additional return airflow be provided in the janitorial closets 
in 3100 and 5300 to ensure that the ASHRAE requirement of a minimum of 10 air 
changes per hour is met [ASHRAE 2013]. 
2. Ensure that all patient bathrooms meet minimum total air changes per hour as specified 
by ASHRAE. ASHRAE standard 2013-170 requires inpatient bathrooms to have at 
least 10 air changes per hour. 
3. Ensure that OxyCide dispensers are calibrated to effectively dilute the product to a pH 
of 3. If OxyCide is not effectively diluted, a pH of less than 3 may increase skin, eye, 
and respiratory symptoms in exposed employees. 
4. We recommend that management replace the current open-face buckets used to 
hold the wipes and OxyCide liquid product with bucket wipe dispensers. Exposure 
to vapors from the Oxycide may be minimized by requiring lids for the containers 
that EVS staff use to hold the Oxycide liquid product and wipes. Several companies 
make bucket wipe dispensers that could be used to allow wipes to be pulled from the 
Oxycide containers while minimizing vapor exposure. 








Administrative controls refer to employer-dictated work practices and policies to reduce or 
prevent hazardous exposures. Their effectiveness depends on employer commitment and 
employee acceptance. Regular monitoring and reinforcement are necessary to ensure that 
policies and procedures are followed consistently. 
1. Minimize the use of sporicidal disinfectants like OxyCide in non-patient care areas. 
2. Review the process for Occupational Safety and Health Administration Form 
300 reporting and maintenance to assure that all reportable injuries are recorded, 
regardless of whether a workers’ compensation claim is filed. Consider implementing 
a comprehensive system for reporting and tracking workplace injuries and illnesses 
that includes reports of near-misses, minor injuries and illnesses, and employee safety 
concerns. This information should be reviewed by the Safety Officer on a regular 
basis to identify hazards, implement risk-reduction strategies, and prevent significant 
injuries and illnesses. 
3. We recommend that management implement a reporting system that would allow 
employees to report work-related symptoms, with the option to remain anonymous 
for employees who do not wish to be identified. As a performance indicator for 
disinfection and sterilization, HICPAC recommends that healthcare facilities develop 
a mechanism for the reporting of all adverse health events potentially resulting from 
exposure to sporicidal disinfectants and sterilants. These reports should be reviewed 
regularly, and the facility should implement controls to prevent future exposures. 
4. Health and safety concerns related to cleaning and disinfecting products should be 
regularly evaluated. An annual post-shift survey of acute symptoms may be a useful 
tool for (1) alerting management to symptoms experienced by cleaning staff and (2) 
identifying areas of the hospital where symptoms may be more commonly reported 
and exposures may be higher. Such a system may allow employees with symptoms 
related to cleaning or disinfecting products to be offered relocation to an area or unit 
of the hospital with lower risk of exposure to sporicidal disinfectants. This type of 
evaluation may also help the facility identify additional controls to reduce employee 
exposure. 
5. Employees should report new, persistent, or worsening symptoms to their personal 
healthcare provider and, as instructed by their employer, to a designated individual at 
their workplace. An individualized management plan (such as assigning an affected 
employee to a different work location) is sometimes required, as indicated by medical 
findings and recommendations of the physician. Employees with symptoms should 
provide their personal physicians or other healthcare providers with a copy of this 
report. 
6. A team approach should be used when introducing a new cleaning product or system. 
A committee of EVS staff, infection preventionists, and occupational health and safety 
representatives should be convened when new cleaners and sporicidal disinfectants 
are chosen for the facility. Acquiring buy-in from these different groups prior to 
investment is key to implementing a new cleaning product or system. A trial period 




with a new cleaning system or product, with selected trial units or areas of the hospital, 
could be used to acquire feedback from stakeholders, including EVS staff, to evaluate 
new cleaning systems or products. Evaluation of a new cleaning system or product 
should consider effectiveness, cost, and employee health and safety concerns. 
7. Ensure employees understand the potential hazards from exposure to cleaning 
products and how to protect themselves. OSHA’s Hazard Communication Standard, 
also known as the “Right to Know Law” [29 CFR 1910.1200] requires that employees 
are informed of potential work hazards and trained on associated safe practices, 
procedures, and protective measures. Ensure employees have access and are informed 
of potential hazards and trained on the associated safe practices per the information 
found in the cleaning products’ Safety Data Sheets. We found that some hospital 
employees have the impression that because the chemicals contained in OxyCide are 
similar to common household products, there is little health risk from exposure. The 
2008 HICPAC Guideline recommends that each worker be informed of the possible 
health effect(s) of his or her exposure to chemicals. Specifically, employees should 
be educated on the documented health risks from exposure to HP, AA and PAA, as 
well as chemicals found in other cleaners at the hospital. This information should be 
consistent with Safety Data Sheets, Environmental Protection Agency regulations, 
and OSHA requirements and identify areas and tasks where there is the potential for 
exposure. 
8. In an interim letter dated October 19, 2015, we observed that OxyCide was formerly 
used as a spray cleaner by some staff in some units. Because spraying OxyCide may 
increase an employee’s risk of inhalational exposure, we recommend that employees 
discontinue the practice of using OxyCide as a spray cleaner. Instead, employees 
should continue using rags or wipes to apply OxyCide to surfaces. 
Personal Protective Equipment 
Personal protective equipment is the least effective means for controlling hazardous 
exposures. Proper use of personal protective equipment requires a comprehensive program 
and a high level of employee involvement and commitment. The right personal protective 
equipment must be chosen for each hazard. Supporting programs such as training, change-out 
schedules, and medical assessment might be needed. Personal protective equipment should 
not be the sole method for controlling hazardous exposures. Rather, personal protective 
equipment should be used until effective engineering and administrative controls are in place. 
1.		 Require employees to wear extended cuff nitrile gloves or rubber gloves when using 
OxyCide and goggles or a face shield while dispensing and pouring OxyCide into or 
out of the bucket on their cleaning cart. 
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Appendix A : Supplemental Analyses 
All participants - Asthma 
Twenty percent (n=32) of participants reported ever being diagnosed with asthma, which 
was 2.4 times higher (95% confidence interval (CI) = 1.6-3.4) than expected, compared to 
the U.S. adult population. Current asthma was reported by 14% (n=23) of participants and 
was 2.3 times higher (95% CI= 1.5-3.6) than expected. A total of 15 (9%) participants had 
adult-onset asthma, which was 2.8 times higher (95% CI=1.7-4.7) than expected. The pre-
hire adult-onset asthma incidence density was 4.8 cases per 1000 person-years. The post-hire 
adult-onset asthma incidence density was 5.5 cases per 1000 person-years. This produced an 
incidence density ratio of 1.15, which shows no difference in adult-onset asthma between the 
pre-hire and post-hire group. 
Health outcomes by EVS and non-EVS staff 
Among EVS participants, the most commonly reported health outcomes were watery 
eyes (42%), nasal problems (41%), asthma-like symptoms (28%), and shortness of breath 
(16%). The most commonly reported health outcomes for non-EVS staff were use of allergy 
medicine (43%), nasal problems (43%), watery eyes (38%), and asthma-like symptoms 
(29%) (Table A2).  Only the use of allergy medication and nasal allergies diagnosis (p≤0.05) 
were significant between EVS and non-EVS participants (Table A1). When compared to 
expected values for the U.S. adult population, EVS staff were not significantly different for 
the prevalence of shortness of breath, cough, wheeze, and watery eyes. Non-EVS staff were 
not significantly different when compared to the U.S. adult population for the prevalence of 
cough, wheeze and watery eyes. However, they were 57% less likely to report shortness of 
breath than the U.S. adult population and this difference was significant (SMR= 0.43, CI= 
0.21-0.89). 





Table A1. Health outcomes of EVS and non-EVS Staff, NIOSH survey August-September 
Health Outcome EVS (n= 79) Non-EVS (n= 84) p* 
Cough 3 (4%) 6 (7%) 0.50 
Shortness of Breath 13 (16%) 8 (10%) 0.24 
Wheeze† 11 (14%) 15 (18%) 0.53 
Chest Tightness† 11 (14%) 7 (8%) 0.32 
Asthma Attack† 2 (3%) 6 (7%) 0.28 
Asthma Medicine 8 (10%) 10 (12%) 0.81 
Allergy Medicine 12 (15%) 36 (43%) ≤0.05 
Asthma-Like Symptoms§ 22 (28%) 24 (29%) 1.00 
Nasal Problems† 32 (41%) 36 (43%) 0.87 
Watery Eyes† 33 (42%) 32 (38%) 0.75 
Skin Problems† 12 (15%) 19 (23%) 0.24 
Asthma 
Ever 13 (16%) 19 (23%) 0.33 
Current 10 (13%) 13 (15%) 0.66 
Nasal Allergies 10 (13%) 27 (32%) ≤0.05 
Note: EVS=environmental services staff 
* P-values calculated using Chi-Square or Fisher’s Exact Test; p ≤ 0.05 considered significant
† In the past 12 months.
§ Asthma-like symptoms were defined as current use of asthma medicine and/or one or more of the 
following symptoms in the last 12 months: wheezing or whistling in the chest, awakening with a feeling of 
chest tightness, or attack of asthma. 
Health outcomes by OxyCide use 
A comparison of health outcomes between OxyCide users and non-users are shown in Table 
A2. The most commonly reported symptom among OxyCide users were watery eyes (45%), 
nasal problems (40%), and asthma-like symptoms (31%). Commonly reported symptoms 
among OxyCide non-users were nasal problems (44%), use of allergy medicine (38%), 
and watery eyes (35%). Only nasal allergy diagnosis and the use of allergy medication was 
significantly different between users and non-users (p≤0.05). Both OxyCide users and non-
users were also not significantly different from the U.S. adult population for upper and lower 
respiratory symptoms. 
The prevalence of ever having a physician diagnosis of asthma among OxyCide users 
was 2.1 times (95% CI = 1.2-3.7) that of the expected U.S. adult population. Similarly, 
the prevalence of current asthma among OxyCide users was 2.5 times (95% CI = 1.4-4.6) 
the expected prevalence for the U.S. adult population. Among OxyCide non-users, the 
prevalence of ever having a physician diagnosis of asthma or current asthma was also higher 
than the expected values for the U.S. adult population. Among OxyCide non-users, the 
prevalence of ever having physician diagnosed asthma was 2.6 times (95% CI = 1.6-4.2) and 
current asthma was 2.2 times (95% CI = 1.2-4.0), the expected prevalence for the U.S. adult 
population. The prevalence of work-related symptoms was generally higher in OxyCide users 
(Figure A1). 
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                    Table A2. Symptoms and self-reported diagnoses of the survey participants (N=163),
by OxyCide Use, NIOSH survey, August-September 2015 
Symptom Disinfectant Use         (n= 78 ) 
No Disinfectant Use 
(n= 85 ) p* 
Nasal Problems† 31 (40%) 37 (44%) 0.64 
Watery Eyes† 35 (45%) 30 (35%) 0.26 
Asthma-Like 
Symptoms§ 24 (31%) 22 (26%) 0.60 
Skin Problems† 12 (15%) 19 (22%) 0.32 
Wheeze† 12 (15%) 14 (16%) 1.00 
Shortness of Breath 11 (14%) 10 (12%) 0.82 
Chest Tightness† 10 (13%) 8 (9%) 0.62 
Cough 5 (6%) 4 (5%) 0.74 
Asthma Attack† 3 (4%) 5 (6%) 0.72 
Medication Use 
Allergy Medicine 16 (21%) 32 (38%) <0.05 
Asthma Medicine 10 (13%) 8 (9%) 0.62 
Diagnosis 
Asthma 
Ever 14 (18%) 18 (21%) 0.69 
Current 12 (15%) 11 (13%) 0.66 
Nasal Allergies 11 (14%) 26 (31%) <0.05 
Notes:
 
*P values calculated using Chi-square or Fisher’s Exact Test

†In the past 12 months.
§Asthma-like symptoms were defined as current use of asthma medicine and/or one or more of the 
following symptoms in the last 12 months: wheezing or whistling in the chest, awakening with a feeling of 
chest tightness, or attack of asthma. 
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Results for the 68 EVS participants who reported OxyCide use are shown in Table A3. 



































*Work-related symptoms were defined as symptoms that improved away from the facility, either on days 
off or on vacation. 
† In the past 12 months.
§ Asthma-like symptoms were defined as current use of asthma medicine and/or one or more of the 
following symptoms in the last 12 months: wheezing or whistling in the chest, awakening with a feeling of 
chest tightness, or attack of asthma. 
Acute symptoms in EVS staff during a work shift 
Table A4 shows the results of logistic regression of acute symptoms during a work-shift in 
EVS staff in relation to exposure to acetic acid, hydrogen peroxide, and peracetic acid. 
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Characteristic (N=35) 
Age, years, median (range) 40 (20-67) 
Tenure, years, median (range) 3.5 (0.21- 26.2) 
Male, n (%) 
Race, n (%) 
15 (43%) 
     White 11 (31%)
 Black 17 (49%) 
     Asian 2 (6%)
 Other† 4 (11%)
 Unknown‡ 
Smoking status, n (%)
1 (3%) 
Current 8 (23%)
 Former 2 (6%)
 Never 25 (71%) 
Demographics of Air Sampling, Acute Symptom Survey, and Health and Work History 
Questionnaire Participants 
Demographic information for cleaning staff who participated in the air sampling, post-shift 
survey, and health and work history questionnaire can be seen in Table A5. The median age 
of participants was 40 years and ranged from 20 to 67 years. Forty-three percent were male. 
Median tenure was 3.5 years and ranged from 0.21 to 26.2 years. Current, former, and never 
smokers accounted for 23%, 6%, and 71% of participants, respectively. 
Table A5. Demographic characteristics of air sampling, acute symptom survey and health and 
work history questionnaire participants, August-September 2015 
Hospital Cleaning Staff 
† Includes participants who indicated more than one race.
‡ Participants who refused to indicate a race. 
Comparison between Responses Observed in the Post-Shift Acute Symptom Survey and in the 
Health and Work History Questionnaire 
Thirty-five EVS employees participated in the health and work history questionnaire, 
post-shift survey, and personal air sampling. In Figure A2, we show the prevalence of 
symptoms reported by 35 employees in both the post-shift survey and health and work 
history questionnaire. Nasal and eye irritation were the most commonly reported symptoms 
in both surveys. Cough, nasal, and eye symptoms were more often reported in the post-shift 
survey as acute symptoms that were experienced during their work shift. Overall, employees 
reported similarly for acute symptoms that began during their work shift and symptoms 
reported as usually occurring or as having occurred in the last year. 
We also explored associations between exposure to hydrogen peroxide, acetic acid, and 
peracetic acid and symptoms reported as occurring in the previous 12 months using logistic 
regression (Table A6). Asthma-like symptoms, nasal irritation, eye irritation, wheeze, and 
shortness of breath were associated with exposure to acetic acid, hydrogen peroxide, and 
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peracetic acid. Shortness of breath was significantly associated with hydrogen peroxide 
exposure. Additionally, exposure to hydrogen peroxide was associated with cough, chest 
tightness, and allergy medication use. We also explored associations between the use 
of cleaning products containing known asthmagens and work-related acute symptoms 
using logistic regression. The use of any single cleaning product containing quaternary 
ammonium compounds, bleach, ethanolamines or any combination of these products was 
not significantly associated with work-related acute symptoms. Overall, we observed similar 
reporting of work-related symptoms in the post-shift acute symptom survey and symptoms 
that employees had experienced in the last year. We observed associations between exposure 
to hydrogen peroxide, acetic acid, and peracetic acid and work-related symptoms in EVS 
employees who participated in both the post-shift acute symptom survey and health and work 
history questionnaire. 
Figure A2. Prevalence of work-related symptoms reported by employees in the post-shift acute symptom 
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The Health Hazard Evaluation Program investigates possible health hazards in the workplace 
under the authority of the Occupational Safety and Health Act of 1970 (29 U.S.C. § 669(a) 
(6)). The Health Hazard Evaluation Program also provides, upon request, technical assistance 
to federal, state, and local agencies to investigate occupational health hazards and to prevent 
occupational disease or injury. Regulations guiding the Program can be found in Title 42, Code 
of Federal Regulations, Part 85; Requests for Health Hazard Evaluations (42 CFR Part 85). 
Disclaimer 
The recommendations in this report are made on the basis of the findings at the workplace 
evaluated and may not be applicable to other workplaces. 
Mention of any company or product in this report does not constitute endorsement by the 
National Institute for Occupational Safety and Health (NIOSH). 
Citations to Web sites external to NIOSH do not constitute NIOSH endorsement of the 
sponsoring organizations or their programs or products. NIOSH is not responsible for the 
content of these Web sites. All Web addresses referenced in this document were accessible as 
of the publication date. 
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